Global Contract Manufacturing Market Analysis
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Mar, 2011| No. of Pages : 70
List of Figures:
Figure 4-1: Global - Pharma Contract Manufacturing Market (Billion US$), 2009-2013
Figure 4-2: India - Pharma Contract Manufacturing Market (Million US$), 2009-2013
Figure 4-3: India - API Export (Billion US$), 2009-2013
Figure 4-4: China - Finished Drugs Trade (Billion US$), 2009-2013
Figure 4-5: China - API Export (Billion US$), 2008-2013
List of Tables:
Table 4-1: India - Key Contract Manufacturers and Their Business Segments
Table 4-2: Brazil - Key Contract Manufacturers and Their Business Segments
Table 4-3: China - Key Contract Manufacturers and Their Business Segments
Table 4-4: Singapore - Key Contract Manufacturers and Their Business Segments
Table 4-5: Russia - Key Contract Manufacturers and Their Business Segments
Table 4-6: Ukraine - Key Contract Manufacturers and Their Business Segments
Table 4-7: Mexico - Key Contract Manufacturers and Their Business Segments
Table 4-8: Vietnam - Key Contract Manufacturers and Their Business Segments
Table 4-9: Bangladesh - Key Contract Manufacturers and Their Business Segments
Table 4-10: Egypt - Key Contract Manufacturers and Their Business Segments
Table 4-11: South Korea - Key Contract Manufacturers and Their Business Segments
Table 6-1: Catalent Pharma Solutions, Inc. - Strengths & Weaknesses
Table 6-2: Lonza Group Ltd. - Strengths & Weaknesses
Table 6-3: Althea Technologies - Strengths & Weaknesses
Table 6-4: Dishman Pharmaceuticals and Chemicals Ltd - Strengths & Weaknesses
Table 6-5: Jubilant Life Sciences Ltd - Strengths & Weaknesses
Table 6-6: NextPharma - Strengths & Weaknesses
Table 6-7: Wockhardt - Strengths & Weaknesses